Radiation treatment in age-related macular degeneration

Christina Flaxel, Paul T. Finger

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Age-related macular degeneration (AMD) is a leading cause of rapid and severe visual loss and legal blindness in developed countries (1,2). Ten million Americans are visually disabled due to AMD and 10% of patients aged 66 to 74 show signs of AMD (3,4). Estimated prevalence is from 7% to 30% in persons aged 75 to 85 years (4–6). The “wet” form of AMD is responsible for the most severe and rapid vision loss. In North America, 200,000 to 400,000 people will develop this form of AMD each year. Wet AMD accounts for 12% of cases overall but 90% of cases of legal blindness (see chap 8 on Wet AMD) (4).

Original languageEnglish (US)
Title of host publicationAge-Related Macular Degeneration, Second Edition
PublisherCRC Press
Pages233-246
Number of pages14
ISBN (Electronic)9781420019865
ISBN (Print)9780849372148
StatePublished - Jan 1 2007

Fingerprint

Macular Degeneration
Radiation
Blindness
Therapeutics
North America
Developed Countries
Macular Degeneration, Age-Related, 4

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Flaxel, C., & Finger, P. T. (2007). Radiation treatment in age-related macular degeneration. In Age-Related Macular Degeneration, Second Edition (pp. 233-246). CRC Press.

Radiation treatment in age-related macular degeneration. / Flaxel, Christina; Finger, Paul T.

Age-Related Macular Degeneration, Second Edition. CRC Press, 2007. p. 233-246.

Research output: Chapter in Book/Report/Conference proceedingChapter

Flaxel, C & Finger, PT 2007, Radiation treatment in age-related macular degeneration. in Age-Related Macular Degeneration, Second Edition. CRC Press, pp. 233-246.
Flaxel C, Finger PT. Radiation treatment in age-related macular degeneration. In Age-Related Macular Degeneration, Second Edition. CRC Press. 2007. p. 233-246
Flaxel, Christina ; Finger, Paul T. / Radiation treatment in age-related macular degeneration. Age-Related Macular Degeneration, Second Edition. CRC Press, 2007. pp. 233-246
@inbook{ed62bf184c9f401b84677ecb4ff0f2d1,
title = "Radiation treatment in age-related macular degeneration",
abstract = "Age-related macular degeneration (AMD) is a leading cause of rapid and severe visual loss and legal blindness in developed countries (1,2). Ten million Americans are visually disabled due to AMD and 10{\%} of patients aged 66 to 74 show signs of AMD (3,4). Estimated prevalence is from 7{\%} to 30{\%} in persons aged 75 to 85 years (4–6). The “wet” form of AMD is responsible for the most severe and rapid vision loss. In North America, 200,000 to 400,000 people will develop this form of AMD each year. Wet AMD accounts for 12{\%} of cases overall but 90{\%} of cases of legal blindness (see chap 8 on Wet AMD) (4).",
author = "Christina Flaxel and Finger, {Paul T.}",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780849372148",
pages = "233--246",
booktitle = "Age-Related Macular Degeneration, Second Edition",
publisher = "CRC Press",

}

TY - CHAP

T1 - Radiation treatment in age-related macular degeneration

AU - Flaxel, Christina

AU - Finger, Paul T.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Age-related macular degeneration (AMD) is a leading cause of rapid and severe visual loss and legal blindness in developed countries (1,2). Ten million Americans are visually disabled due to AMD and 10% of patients aged 66 to 74 show signs of AMD (3,4). Estimated prevalence is from 7% to 30% in persons aged 75 to 85 years (4–6). The “wet” form of AMD is responsible for the most severe and rapid vision loss. In North America, 200,000 to 400,000 people will develop this form of AMD each year. Wet AMD accounts for 12% of cases overall but 90% of cases of legal blindness (see chap 8 on Wet AMD) (4).

AB - Age-related macular degeneration (AMD) is a leading cause of rapid and severe visual loss and legal blindness in developed countries (1,2). Ten million Americans are visually disabled due to AMD and 10% of patients aged 66 to 74 show signs of AMD (3,4). Estimated prevalence is from 7% to 30% in persons aged 75 to 85 years (4–6). The “wet” form of AMD is responsible for the most severe and rapid vision loss. In North America, 200,000 to 400,000 people will develop this form of AMD each year. Wet AMD accounts for 12% of cases overall but 90% of cases of legal blindness (see chap 8 on Wet AMD) (4).

UR - http://www.scopus.com/inward/record.url?scp=85056682671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056682671&partnerID=8YFLogxK

M3 - Chapter

SN - 9780849372148

SP - 233

EP - 246

BT - Age-Related Macular Degeneration, Second Edition

PB - CRC Press

ER -